Market Overview

UPDATE: ISI Group Upgrades Bruker Corporation to Buy, Raises PT

Related BRKR
Pressure Biosciences CEO On Its Beaten Down Stock: 'We Can Now Begin To Focus On The Area That Is Most Important'
9 Stocks Which Rallied Four Days, Then Sold Off Yesterday

In a report published Monday, ISI Group upgraded its rating on Bruker Corporation (NASDAQ: BRKR) to Buy, and raised its price target from $15.00 to $19.00.

ISI Group noted, “We are upgrading shares of Bruker in conjunction with ISI's transition to an absolute return rating system and are raising our price target from $15.00 to $19.00. Under the leadership of new CFO Wagner, we expect cost containment and streamlining efforts to benefit operating margins and free cash flow over the medium term. EPS power should be further buffeted by continued strong new product momentum that should also translate into organic revenue growth upside. Ultimately, we expect these tailwinds to outweigh any potential drag from funding challenges in the academic channel, and look for improved macro conditions to be a demand buffer for the industrial and applied markets.”

Bruker Corporation closed on Friday at $15.98.

Latest Ratings for BRKR

Jan 2017BarclaysDowngradesOverweightEqual-Weight
Dec 2016JP MorganDowngradesNeutralUnderweight
Nov 2016Leerink SwannAssumesMarket Perform

View More Analyst Ratings for BRKR
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Upgrades Analyst Ratings


Related Articles (BRKR)

View Comments and Join the Discussion!